Enclosed is the un-audited financial results (standalone and consolidated) for the quarter and half year ended 30-September-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.7 pts less than Nifty Microcap 250 and 3.6 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Elixir Capital, a capital markets-focused NBFC/holding company, reported un-audited results for Q2 FY26 and the half-year ended September 2025. On a standalone basis, Q2 profit after tax came in at Rs 73.73 lakhs (EPS Rs 1.27) versus Rs 75.07 lakhs a year ago, with most of the profit coming from other operating income. On a consolidated basis, total income for the quarter fell sharply to Rs 1,117.97 lakhs from Rs 2,327.21 lakhs in Q2 FY25 (roughly a 52% drop), and net profit after minority interest was Rs 170.79 lakhs (EPS Rs 2.94). For the half-year, consolidated net profit dropped to Rs 443.39 lakhs from Rs 1,471.23 lakhs last year. Auditor JMT & Associates issued an unmodified review opinion on both sets of results. The consolidated cash flow statement shows a sharp negative operating cash flow of Rs (1,294) lakhs, driven by higher working capital deployment.
The headline consolidated revenue and profit numbers have weakened meaningfully versus the prior year, even as standalone earnings remain stable, so investors should focus on subsidiary-level performance and the negative operating cash flow. The clean (unmodified) auditor opinion is a positive, but the sharp revenue decline and cash burn are near-term negatives for the stock.